Articles |
From the Copenhagen Male Study, Epidemiological Research Unit, Rigshopitalet, State University Hospital, Copenhagen (J.J., H.O.H., P.S., F.G.); and the Glostrup Population Studies, Department of Internal Medicine C, Glostrup Hospital, University of Copenhagen (H.O.H.), Denmark.
Correspondence to Jørgen Jeppesen, the Copenhagen Male Study, Epidemiological Research Unit, 7122 Rigshospitalet, DK-2200 Copenhagen, Denmark.
Abstract High triglyceride (TG) and low HDL cholesterol (HDL-C) is the characteristic dyslipidemia seen in insulin-resistant subjects. We examined the role of this dyslipidemia as a risk factor of ischemic heart disease (IHD) compared with that of high LDL cholesterol (LDL-C) in the Copenhagen Male Study. In total 2910 white men, aged 53 to 74 years, free of cardiovascular disease at baseline, were subdivided into four groups on the basis of fasting concentrations of serum TG, HDL-C, and LDL-C. "High TGlow HDL-C" was defined as belonging to both the highest third of TG and the lowest third of HDL-C; this group encompassed one fifth of the population. "High LDL-C" was defined as belonging to the highest fifth of LDL-C. A control group was defined as not belonging to either of these two groups. "Combined dyslipidemia" was defined as belonging to both dyslipidemic groups. Age-adjusted incidence of IHD during 8 years of follow-up was 11.4% in high TGlow HDL-C, 8.2% in high LDL-C, 6.6% in the control group, and 17.5% in combined dyslipidemia. Compared with the control group, relative risks of IHD (95% confidence interval), adjusted for potentially confounding factors or covariates (age, body mass index, alcohol consumption, physical activity, noninsulin-dependent diabetes, hypertension, smoking, and social class), were 1.5 (1.0-2.1), P<.05; 1.3 (0.9-2.0), P=.16; and 2.4 (1.5-4.0), P<.01, in the three dyslipidemic groups, respectively. In conclusion, the present results showed that high TGlow HDL-C, the characteristic dyslipidemia seen in insulin-resistant subjects, was at least as powerful a predictor of IHD as isolated high LDL-C. The results suggest that efforts to prevent IHD should include intervention against high TGlow HDL-C, and not just against hypercholesterolemia.
Key Words: dyslipidemia high-density lipoprotein cholesterol ischemic heart disease triglycerides low-density lipoprotein cholesterol
This article has been cited by other articles:
![]() |
B. E. Aouizerat, M. B. Engler, Y. Natanzon, M. Kulkarni, J. Song, C. Eng, J. Huuskonen, C. Rivera, A. Poon, M. Bensley, et al. Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia J. Lipid Res., April 1, 2006; 47(4): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Klibansky, A. Chin, I. J. Duignan, and J. M. Edelberg Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1387 - H1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boden and M. Laakso Lipids and Glucose in Type 2 Diabetes: What is the cause and effect? Diabetes Care, September 1, 2004; 27(9): 2253 - 2259. [Full Text] [PDF] |
||||
![]() |
R. M. Krauss Lipids and Lipoproteins in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1496 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Hurst and R. W. Lee Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management Ann Intern Med, November 18, 2003; 139(10): 824 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pereira, D. R. Jacobs Jr, L. Van Horn, M. L. Slattery, A. I. Kartashov, and D. S. Ludwig Dairy Consumption, Obesity, and the Insulin Resistance Syndrome in Young Adults: The CARDIA Study JAMA, April 24, 2002; 287(16): 2081 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lemieux, B. Lamarche, C. Couillard, A. Pascot, B. Cantin, J. Bergeron, G. R. Dagenais, and J.-P. Despres Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study Arch Intern Med, December 10, 2001; 161(22): 2685 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pascot, I. Lemieux, D. Prud'homme, A. Tremblay, A. Nadeau, C. Couillard, J. Bergeron, B. Lamarche, and J.-P. Despres Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity J. Lipid Res., December 1, 2001; 42(12): 2007 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Westerbacka, A. Seppala-Lindroos, and H. Yki-Jarvinen Resistance to Acute Insulin Induced Decreases in Large Artery Stiffness Accompanies the Insulin Resistance Syndrome J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5262 - 5268. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mohan, R. Deepa, S. Shanthi Rani, and G. Premalatha Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5) J. Am. Coll. Cardiol., September 1, 2001; 38(3): 682 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.W.G. Yarnell, C. C. Patterson, P. M. Sweetnam, H. F. Thomas, D. Bainton, P. C. Elwood, C. H. Bolton, and N. E. Miller Do Total and High Density Lipoprotein Cholesterol and Triglycerides Act Independently in the Prediction of Ischemic Heart Disease?: Ten-Year Follow-Up of Caerphilly and Speedwell Cohorts Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1340 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couillard, J.-P. Despres, B. Lamarche, J. Bergeron, J. Gagnon, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, and C. Bouchard Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides : Evidence From Men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1226 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jeppesen, H. O. Hein, P. Suadicani, and F. Gyntelberg High Triglycerides and Low HDL Cholesterol and Blood Pressure and Risk of Ischemic Heart Disease Hypertension, August 1, 2000; 36(2): 226 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haim, M. Benderly, D. Brunner, S. Behar, E. Graff, H. Reicher-Reiss, and U. Goldbourt Elevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart Disease : The Bezafibrate Infarction Prevention (BIP) Registry Circulation, August 3, 1999; 100(5): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Slyper Childhood Obesity, Adipose Tissue Distribution, and the Pediatric Practitioner Pediatrics, July 1, 1998; 102(1): 4e - 4. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |